SESSION 2: Modern Hepatology: Integrating Emerging Therapies with Best Practices
Tracks
Plenary Hall
| Friday, February 6, 2026 |
| 11:10 AM - 12:15 PM |
Speaker
Dr. Al Warith Al Hashemi
Consultant General, Hepatobillary & Liver Transplant Surgery
The Royal Hospital
Liver Transplantation Program in Oman: Current Status & Future Plans
11:10 AM - 11:25 AMBiography
Dr. Khalid Al Naamani
Senior Consultant Physician, Gastroenterologist, Therapeutic Endoscopist, Hepatology, and Liver Transplantation
Oman International Hospital
MAFLD/NASH: 2025 Update
11:25 AM - 11:40 AMBiography
Dr. Khalid Al-Naamani is a senior consultant specializing in Gastroenterology, Advanced Therapeutic Endoscopy, Hepatology, and Liver Transplantation at the Medical City for Military and Security Services and Sultan Qaboos University Hospital in Muscat, Oman.
He graduated from Sultan Qaboos University in 1998 and subsequently completed advanced training in Internal Medicine, Gastroenterology, Advanced Therapeutic Endoscopy, Hepatology, and Liver Transplantation at McGill University, Montreal, Canada, from 2001 to 2008. Dr. Al-Naamani is a Fellow of the Royal College of Physicians and Surgeons of Canada (Internal Medicine and Gastroenterology), the Royal College of Physicians of Edinburgh, the American College of Physicians, and the American Gastroenterology Association.
Dr. Shiva Kumar
Medical Director of Liver Transplantation
Chair, Gastroenterology & Hepatology, Cleveland Clinic Abu Dhabi
New and Emerging Therapies in Cholestatic Liver Diseases
11:40 AM - 11:55 AMBiography
Dr Shiva Kumar currently serves as Chair of Gastroenterology & Hepatology and Medical Director of Liver Transplantation at Cleveland Clinic Abu Dhabi, UAE. He completed fellowship training in Gastroenterology & Hepatology at the Mayo Clinic in Rochester, Minnesota and a clinical fellowship in Hepatology & Liver Transplant medicine at the University of Texas Southwestern Medical Center in Dallas, Texas. He also holds a Master of Science degree in Healthcare Management from the University of Texas at Dallas Jindal School of Business.
Dr. Zakariya Al Naamani
HCC Therapy: What is new?
11:55 AM - 12:10 PMBiography